Major indices finish lower amid GE earnings disappointment >>> READ MORE

3 Healthcare Stocks With Healthy Dividends

Steady income helps ease these stocks' uncertainty

    View All  


AstraZeneca185Dividend Yield: 5.5%

AstraZeneca (AZN) — like rival GlaxoSmithKline — is in the midst of a scandal in China, all while the company is suffering from slipping revenue and earnings. Like many big-name global drugmakers, the company is under intense pressure from generic competitors.

Still, investors can take some solace in AZN’s steady and ample dividend. AstraZeneca has been rewarding shareholders for more than two decades, paying semiannually. AZN usually pays out a larger dividend earlier in the year, with a smaller one to come later; based on AstraZeneca’s last two payouts, the stock yields roughly 5.5%.

That sure makes the company’s shrug-worthy 7% year-to-date climb a little sweeter, eh?

The global healthcare name also boasts $7 billion in annual operating cash flow and more than $8 billion in cash and investments — numbers that make that 5.5% yield seem plenty sustainable. Plus, if the company strikes it rich with the next big drug — a possibility considering it’s teaming up with a private biotech firm to collaborate on a new anemia treatment — you’ll get the best of both worlds.

As of this writing, Alyssa Oursler did not hold a position in any of the aforementioned securities.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC